SCHEMBL23913808

SCHEMBL23913808

C=C1C(=O)O[C@H](c2ccc(OC)cc2)[C@@H]1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.44
HPGD P15428 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
PTGS2 P35354 2/20 0.44
TP53 P04637 1/20 0.44
MAOA P21397 1/20 0.44
MAPK1 P28482 2/20 0.42
TSHR P16473 1/20 0.42
MAOB P27338 2/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 2/20 0.41
POLB P06746 1/20 0.41
THRB P10828 1/20 0.41
HTT P42858 1/20 0.41
BLM P54132 1/20 0.41
ALDH1A1 P00352 3/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23914102 1.00 MAPT (0.44) MAPTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL23914083 0.83 ALDH1A1 (0.45) MAPTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL14427628 0.80 BRD4 (0.39) RAB9ASMN1; SMN2MAOAMAOBKMT2A
SCHEMBL14439399 0.80 BRD4 (0.39) RAB9ASMN1; SMN2MAOAMAOBKMT2A
SCHEMBL23914375 0.80 BRD4 (0.39) RAB9ASMN1; SMN2MAOAMAOBKMT2A
SCHEMBL23913947 0.80 ALDH1A1 (0.52) MAPTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL23914088 0.80 ALDH1A1 (0.52) MAPTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL23913793 0.78 ACHE (0.44) MAPTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL23914267 0.77 KMT2A (0.44) MAPTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL15256950 0.76 MAPT (0.52) MAPTHPGDNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS PURDUE RESEARCH FOUNDATION (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS MIF, LTA, MGAM MAPT 3922/4885HPGD 3331/4885NPC1 4363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.